文献速递其他结缔组织病

硬皮病成纤维细胞通过TGF-β/小窝蛋白-1依赖性分泌色素上皮衍生因子抑制血管生成

Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
PubMed 文献 · Ann Rheum Dis · 2017-12-19

本研究探讨TGF-β和小窝蛋白-1(Cav-1)对色素上皮衍生因子(PEDF)表达的调控,以及PEDF在系统性硬化症(SSc)成纤维细胞调节血管生成中的作用。结果显示PEDF在SSc皮肤低Cav-1表达的肌成纤维细胞和网状成纤维细胞中高表达,并被TGF-β诱导;SSc成纤维细胞在器官型模型中抑制血管生成,沉默PEDF可逆转此抗血管生成表型。结论提示TGF-β通过降低成纤维细胞Cav-1表达和后续PEDF分泌抑制SSc血管生成,该通路可能成为新的治疗靶点。

要点

  • SSc皮肤中PEDF在低Cav-1表达的肌成纤维细胞和网状成纤维细胞中高表达,体外可被TGF-β诱导。
  • SSc成纤维细胞在器官型模型中抑制血管生成,沉默PEDF可逆转其抗血管生成表型。
  • 在正常真皮成纤维细胞中沉默Cav-1可重现该抗血管生成模型。

核心结论

  • 数据揭示TGF-β通过降低成纤维细胞Cav-1表达和后续PEDF分泌抑制SSc血管生成的新通路。
  • 该通路可能成为SSc新治疗干预的有前景靶点。

研究设计与样本

  • 研究采用人和小鼠皮肤活检的免疫组化评估成纤维细胞和内皮细胞中PEDF与Cav-1表达。
  • 使用慢病毒短发夹RNA在培养的SSc和对照成纤维细胞中沉默PEDF和Cav-1。
  • 采用器官型成纤维细胞-内皮细胞共培养和Matrigel实验评估血管生成。

主要发现

  • PEDF在SSc皮肤活检中低Cav-1表达的肌成纤维细胞和网状成纤维细胞中高表达,并在体外被TGF-β诱导。
  • SSc成纤维细胞在器官型模型中抑制血管生成,在正常真皮成纤维细胞中沉默Cav-1可重现该模型。
  • 在SSc成纤维细胞中沉默PEDF可逆转其抗血管生成表型。
  • TGF-β受体过度活化的转基因小鼠皮肤活检显示Cav-1降低、PEDF表达升高,伴血管密度减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is characterised by tissue fibrosis and vasculopathy with defective angiogenesis. Transforming growth factor beta (TGF-β) plays a major role in tissue fibrosis, including downregulation of caveolin-1 (Cav-1); however, its role in defective angiogenesis is less clear. Pigment epithelium-derived factor (PEDF), a major antiangiogenic factor, is abundantly secreted by SSc fibroblasts. Here, we investigated the effect of TGF-β and Cav-1 on PEDF expression and the role of PEDF in the ability of SSc fibroblasts to modulate angiogenesis. METHODS: PEDF and Cav-1 expression in fibroblasts and endothelial cells were evaluated by means of immunohistochemistry on human and mouse skin biopsies. PEDF and Cav-1 were silenced in cultured SSc and control fibroblasts using lentiviral short-hairpin RNAs. Organotypic fibroblast-endothelial cell co-cultures and matrigel assays were employed to assess angiogenesis. RESULTS: PEDF is highly expressed in myofibroblasts and reticular fibroblasts with low Cav-1 expression in SSc skin biopsies, and it is induced by TGF-β in vitro. SSc fibroblasts suppress angiogenesis in an organotypic model. This model is reproduced by silencing Cav-1 in normal dermal fibroblasts. Conversely, silencing PEDF in SSc fibroblasts rescues their antiangiogenic phenotype. Consistently, transgenic mice with TGF-β receptor hyperactivation show lower Cav-1 and higher PEDF expression levels in skin biopsies accompanied by reduced blood vessel density. CONCLUSIONS: Our data reveal a new pathway by which TGF-β suppresses angiogenesis in SSc, through decreased fibroblast Cav-1 expression and subsequent PEDF secretion. This pathway may present a promising target for new therapeutic interventions in SSc.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Liakouli V, Elies J, El-Sherbiny YM, et al. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. Ann Rheum Dis. 2017. PMID: 29259049. doi:10.1136/annrheumdis-2017-212120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。